2015
DOI: 10.4103/0019-5154.156477
|View full text |Cite
|
Sign up to set email alerts
|

Transfusion associated graft versus host disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…Lymphocytes carry plenty of speci c human leucocyte antigens which might be recognized by the immune system of blood recipient and caused host in ammatory and immune cascade reaction [24]. Secondly, it is reported that the transfusion-related GVHD was caused by viable or immunocompetent lymphocytes that from the transfusion of stored blood products [25,26]. Moreover, leukocyte may release some pro-in ammatory factors during storage [27].…”
Section: Discussionmentioning
confidence: 99%
“…Lymphocytes carry plenty of speci c human leucocyte antigens which might be recognized by the immune system of blood recipient and caused host in ammatory and immune cascade reaction [24]. Secondly, it is reported that the transfusion-related GVHD was caused by viable or immunocompetent lymphocytes that from the transfusion of stored blood products [25,26]. Moreover, leukocyte may release some pro-in ammatory factors during storage [27].…”
Section: Discussionmentioning
confidence: 99%
“…The clinical signs and symptoms of TA-GVHD are: fever, increased hepatic enzymes, diarrhea, rash progressing from peeling and they occur from three to thirty days after the transfusion [21]. The treatment of TA-GVHD is not effective, so the irradiation of the cell blood components is fundamental for prevention, especially in patients who are in the risk group for developing TA-GVHD [29,[49][50][51].…”
Section: Transfusion-associated Graft-versus-host Disease -Gvhdmentioning
confidence: 99%